| Serial Number | 97278111 |
| Word Mark | DERMAGAN |
| Filing Date | Tuesday, February 22, 2022 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Friday, April 21, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical research and development; Pharmaceutical products development; Product development in the field nutritional supplements for dietary purposes; Scientific research, product research and development services for nutritional and skin care formulations, namely, nutritional supplements, skin care formulations, pharmaceuticals, nutraceuticals, and cosmeceuticals |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 28, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Dermagan Pharmaceuticals LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Scottsdale, AZ 85255 |
| Event Date | Event Description |
| Friday, April 21, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Friday, April 21, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Friday, April 21, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, September 22, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, September 22, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, September 22, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 21, 2022 | ASSIGNED TO EXAMINER |
| Monday, February 28, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 25, 2022 | NEW APPLICATION ENTERED |